XML 46 R38.htm IDEA: XBRL DOCUMENT v3.25.1

Agreement and Plan of Merger - Summary of Total Consideration Paid (Details) - American Depositary Shares - Peak Bio $ in Thousands	Nov. 14, 2024 USD ($) shares
Agreement And Plan Of Merger [Line Items]
Number of ADSs issued and issuable on exercise	16,996,592
Consideration | $	$ 29,973
Company ADSs Issued to Peak Bio Inc. Shareholders
Agreement And Plan Of Merger [Line Items]
Number of ADSs issued and issuable on exercise	12,613,942
Consideration | $	$ 28,129
Company ADSs Issuable on Exercise of November 2022 Peak Investor Warrants and April 2023 Peak Investor Warrants
Agreement And Plan Of Merger [Line Items]
Number of ADSs issued and issuable on exercise	2,764,569
Consideration | $	$ 1,844
Company ADSs Issuable on Exercise of Peak Bio Adjusted Options
Agreement And Plan Of Merger [Line Items]
Number of ADSs issued and issuable on exercise	1,618,081

X

- Definition

Agreement and plan of merger.

+ References

No definition available.

+ Details

Name:	aktx_AgreementAndPlanOfMergerLineItems
Namespace Prefix:	aktx_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Value of equity interests (such as common shares, preferred shares, or partnership interest) issued or issuable to acquire the entity.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 805
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)(4)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479581/805-30-50-1

+ Details

Name:	us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

X

- Definition

Number of shares of equity interests issued or issuable to acquire entity.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 805
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)(4)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479581/805-30-50-1

+ Details

Name:	us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

X

- Details

Name:	us-gaap_StatementClassOfStockAxis=sic_Z8880
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_BusinessAcquisitionAxis=aktx_PeakBioMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementEquityComponentsAxis=aktx_PeakBioIncShareholdersMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementEquityComponentsAxis=aktx_NovemberTwoThousandTwentyTwoPeakInvestorWarrantsAndAprilTwoThousandTwentyThreePeakInvestorWarrantsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementEquityComponentsAxis=aktx_PeakBioAdjustedOptionsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: